Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5785053 | BAYER HLTHCARE | Inserter for the positioning of an intrauterine device |
Dec, 2015
(8 years ago) | |
US7252839 | BAYER HLTHCARE | Delivery system and a manufacturing process of a delivery system |
Nov, 2023
(5 months ago) | |
US11628088 | BAYER HLTHCARE | Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection |
Feb, 2027
(2 years from now) | |
US9615965 | BAYER HLTHCARE | Inserter |
Sep, 2029
(5 years from now) | |
US10561524 | BAYER HLTHCARE | Inserter |
Sep, 2029
(5 years from now) | |
US9668912 | BAYER HLTHCARE | Inserter |
Apr, 2031
(6 years from now) | |
US10987244 | BAYER HLTHCARE | Inserter |
Apr, 2031
(6 years from now) |
Skyla is owned by Bayer Hlthcare.
Skyla contains Levonorgestrel.
Skyla has a total of 7 drug patents out of which 2 drug patents have expired.
Expired drug patents of Skyla are:
Skyla was authorised for market use on 09 January, 2013.
Skyla is available in intrauterine device;intrauterine dosage forms.
Skyla can be used as a method of positioning an intrauterine system by holding an inserter handle with one hand, advancing the inserter through the cervix and into the uterus, and retracting a slider on the handle to release the intrauterine system, a method of positioning an intrauterine system (ius) by determining a depth of the uterus, holding an inserter handle with one hand, inserting the ius into the uterus, and retracting a slider on the handle to release the ius into the uterus.
The generics of Skyla are possible to be released after 01 April, 2031.
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Product(NP) | Jan 09, 2016 |
Drugs and Companies using LEVONORGESTREL ingredient
Market Authorisation Date: 09 January, 2013
Treatment: A method of positioning an intrauterine system by holding an inserter handle with one hand, advancing the inserter through the cervix and into the uterus, and retracting a slider on the handle to rele...
Dosage: INTRAUTERINE DEVICE;INTRAUTERINE